Carbon Dots-Based Nanozyme for Drug-Resistant Lung Cancer Therapy by Encapsulated Doxorubicin/siRNA Cocktail.
Hailing YuKexin TangZeyu CaiXi LinYongquan HuangTing YuQianqian ZhangQiang WangLili WuLei YangHong ShanHui LuoPublished in: International journal of nanomedicine (2023)
Taken together, we uncover the potential role of CDs with a combination of siRNA and chemotherapeutics in overcoming chemoresistance of lung cancer by suppressing MRP1 and oxidation of GSH. Our findings imply its potential of antagonizing chemoresistance to enhance therapeutic efficiency of doxorubicin in clinical practices of lung cancer treatment.